Scinai Immunotherapeutics (SCNI) EBT Margin (2024 - 2026)
Scinai Immunotherapeutics (SCNI) posted EBT Margin of 504.5% for Q1 2026, up 57.02% sequentially from 1173.8% in Q2 2025, and down 23692.0% YoY from N/an in Q1 2025.
Scinai Immunotherapeutics (SCNI) EBT Margin (2024 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported EBT Margin for 3 years, with the latest figure at 504.5% in Q1 2026.
- Quarterly EBT Margin fell 23692.0% year-over-year to 504.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 672.07% (changed N/A YoY) and the FY2025 annual result came in at 1601.59%, up 331285.0% from the prior year.
- EBT Margin rose to 504.5% in Q1 2026 per SCNI's latest filing, from 1173.8% in the prior quarter.
- Over five years, EBT Margin peaked at 6223.21% in Q3 2024 and troughed at 1765.05% in Q4 2024.
- A 3-year average of 502.46% and a median of 504.5% in 2026 frame the typical range for EBT Margin.
- The widest YoY moves for EBT Margin: up 23692 bps in 2026, down 23692 bps in 2026.
- Over 3 years, EBT Margin stood at 1765.05% in 2024, then soared by 33 bps to 1173.8% in 2025, then soared by 57 bps to 504.5% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 504.5%, 1173.8%, and 267.58% for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Scinai Immunotherapeutics | 1.08 Mn | -3.11 Bn | -1.12 Mn | -504.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -504.50% |
| Jun 30, 2025 | -1,173.80% |
| Mar 31, 2025 | -267.58% |
| Dec 31, 2024 | -1,765.05% |
| Sep 30, 2024 | 6,223.21% |